Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests acupuncture in people with epilepsy who have a brain stimulation implant

Studies acupuncture's effects on mood, thinking and seizures in people with epilepsy.

Plain-language title generated from the registry record
Registry title: Clinical and Electrographic Changes in Responsive Neurostimulation System (RNS) Patients With Acupuncture Treatment

Key facts

Where
Houston, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 15 and 60 years old?

Source: NCT04677751, who can take part

Where in United States

  • The University of Texas Health Science Center at HoustonHouston, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
The University of Texas Health Science Center, Houston
Trial code
NCT04677751
Record updated
13 October 2026
Original description
The purpose of this study is to determine effects of Acupuncture on a Patient's mood and cognition,evaluate changes in clinically-reported seizure frequency and severity and analyze effects of Acupuncture on electrographic epileptiform activity stored by the RNS SystemRead full original descriptionShow less

Clinical and Electrographic Changes in RNS System Patients With Acupuncture Treatment

The purpose of this study is to determine effects of Acupuncture on a Patient's mood and cognition,evaluate changes in clinically-reported seizure frequency and severity and analyze effects of Acupuncture on electrographic epileptiform activity stored by the RNS System

Inclusion: Patient implanted with the RNS system; Patient can undergo 12 weeks of acupuncture; Patient is able remain on stable medications for 12 weeks; Patient is able to remain on stable Detection and Stimulation settings for 12 weeks; Patient or/and caregiver is able to understand and sign informed consent and HIPAA authorization; Patient or caregiver able to maintain a seizure diary for duration of study.

Exclusion: Patient has a bleeding disorder, pacemaker, or pregnant; Patient and /or caregiver is unable to sign informed consent to study.

ClinicalTrials.gov NCT04677751